Aecon (ARE) ran another 7% on a Q3 beat, anchored by nuclear revenue which rose ~$150M Y/Y and is showing no signs of slowing down.

Between the print, its recent nuclear contract win, and Brookfield & Cameco’s $80B nuclear partnership with the U.S. government… Aecon is up 30% in the past week and trades near peak valuation.

Disclaimer: Bullpen Finance Inc. is not a registered investment advisor. The information provided is for educational purposes only and should not be considered investment advice. See our terms of service for more information.